Imaxio Email Format
Biotechnology ResearchAuvergne-rhône-alpes, France11-50 Employees
Imaxio is a small biotechnology company based in Lyon, in the Auvergne-Rhône-Alpes region of France. The firm specializes in vaccinology and the prevention of human leptospirosis, a zoonotic disease associated with occupational exposure. It collaborates with health authorities and professionals to reduce occupational risks and raises awareness about the disease in professional settings, supported by its dedicated prevention site leptospirose-prevention.fr. In France, leptospirosis incidence has risen since 2014, exceeding 600 cases per year, with about half of cases among working adults linked to occupational origins. The company operates within the biotechnology research sector, focusing on preventive health and vaccines against leptospirosis. Its client base is primarily health authorities and professionals responsible for occupational health, with its Lyon base anchoring its regional presence.